Why the study?
Asymptomatic cerebral events occur in ~14% of PFA procedures and are linked to microembolic signals during initial PV applications, prompting strategies to reduce them.
Does external pre-application prior to pulsed-field catheter insertion reduce microembolic signals in patients with atrial fibrillation undergoing PFA?
Does external pre-application prior to pulsed-field catheter insertion reduce microembolic signals in patients with atrial fibrillation undergoing PFA?
External pre-application of the PFA catheter in a saline pool reduces microembolic signals during initial pulmonary vein isolation but does not significantly reduce the incidence of silent cerebral lesions.
Pre-PV application may reduce MESs with PulseSelect PFA; leaves open whether this affects silent cerebral lesions.
Background Pulsed-field ablation (PFA) is being increasingly utilised owing to its favourable safety profile and efficacy. Asymptomatic cerebral events have been reported in approximately 14% of PFA procedures, frequently attributed to microembolic signals (MESs) detected during the initial pulmonary vein (PV) applications with the PulseSelect system. Purpose This study aimed to identify strategies for reducing MESs during the initial PV applications in PFA using the PulseSelect system. Methods Forty patients with atrial fibrillation undergoing PFA with the PulseSelect system were assigned to two groups: a conventional method group (n=20) and an external pre-application group (n=20). Carotid echocardiography (Figure a) was performed throughout the procedure, and cerebral magnetic resonance imaging was undertaken one day following the procedure. In the external pre-application group, a single pulse application was delivered in a saline pool prior to catheter insertion (Figure b). In both groups, PV isolation was performed sequentially for the left superior PV (LSPV), left inferior PV (LIPV), right superior PV (RSPV), and right inferior PV (RIPV). Results The external pre-application group exhibited significantly fewer MESs during PV ablation, except for the RSPV (LSPV: 201 ± 105 vs. 112 ± 61, P=0.002; LIPV: 125 ± 63 vs. 58 ± 42, P<0.001; RSPV: 70 ± 64 vs. 34 ± 23, P=0.03). In both groups, MES counts were highest for the LSPV (conventional group: P<0.001; external pre-application group: P<0.001) (Figure c). There was no significant difference in the incidence of postoperative asymptomatic silent cerebral lesions between the groups (35%, P=1.00). Conclusion The external pre-application technique was associated with a reduction in MESs during initial PV isolation using the PulseSelect system.
No takes yet. Share an insight, caveat, or question.
Shiomi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: